Pharmaceutical Microcrystalline Cellulose - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510243734

Publication Date:

October 15, 2024

Pages:

144

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Pharmaceutical Microcrystalline Cellulose was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Pharmaceutical Microcrystalline Cellulose was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharmaceutical Microcrystalline Cellulose was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Pharmaceutical Microcrystalline Cellulose was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Pharmaceutical Microcrystalline Cellulose include International Flavors & Fragrances, JRS Pharma, Shin-Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, Sunhere Pharmaceutical Excipients and Shandong HEAD, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Microcrystalline Cellulose, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Microcrystalline Cellulose by region & country, by Type, and by Application.
The Pharmaceutical Microcrystalline Cellulose market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Microcrystalline Cellulose.
麻豆原创 Segmentation
By Company
International Flavors & Fragrances
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
Ashland
Asahi Kasei
Mingtai
Huzhou Zhanwang
Sunhere Pharmaceutical Excipients
Shandong HEAD
Lotte Chemicals
Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
Yingkou AODA Pharmaceuticals
Accent Microcell
Qufu TIANLI MEDICAL Supplements
C & J Chemical Industries Co., Ltd.
Segment by Type:
Particle Size Less Than 50 Microns
Particle Size 50-100 Microns
Particle Size Greater Than 100 Microns
Segment by Application
Sustained Release Preparation
Tablet
Capsule
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Microcrystalline Cellulose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Microcrystalline Cellulose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Microcrystalline Cellulose in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Pharmaceutical Microcrystalline Cellulose Product Introduction
1.2 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size Forecast
1.2.1 Global Pharmaceutical Microcrystalline Cellulose Sales Value (2019-2030)
1.2.2 Global Pharmaceutical Microcrystalline Cellulose Sales Volume (2019-2030)
1.2.3 Global Pharmaceutical Microcrystalline Cellulose Sales Price (2019-2030)
1.3 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Trends & Drivers
1.3.1 Pharmaceutical Microcrystalline Cellulose Industry Trends
1.3.2 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Drivers & Opportunity
1.3.3 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Challenges
1.3.4 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Microcrystalline Cellulose Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Microcrystalline Cellulose Revenue by Company (2019-2024)
2.3 Global Pharmaceutical Microcrystalline Cellulose Players Sales Volume Ranking (2023)
2.4 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Company Players (2019-2024)
2.5 Global Pharmaceutical Microcrystalline Cellulose Average Price by Company (2019-2024)
2.6 Key Manufacturers Pharmaceutical Microcrystalline Cellulose Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pharmaceutical Microcrystalline Cellulose Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Microcrystalline Cellulose
2.9 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Competitive Analysis
2.9.1 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Microcrystalline Cellulose Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Microcrystalline Cellulose as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Particle Size Less Than 50 Microns
3.1.2 Particle Size 50-100 Microns
3.1.3 Particle Size Greater Than 100 Microns
3.2 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Type
3.2.1 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Microcrystalline Cellulose Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Microcrystalline Cellulose Sales Value, by Type (%) (2019-2030)
3.3 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Type
3.3.1 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pharmaceutical Microcrystalline Cellulose Sales Volume, by Type (2019-2030)
3.3.3 Global Pharmaceutical Microcrystalline Cellulose Sales Volume, by Type (%) (2019-2030)
3.4 Global Pharmaceutical Microcrystalline Cellulose Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sustained Release Preparation
4.1.2 Tablet
4.1.3 Capsule
4.2 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Application
4.2.1 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Microcrystalline Cellulose Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Microcrystalline Cellulose Sales Value, by Application (%) (2019-2030)
4.3 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Application
4.3.1 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pharmaceutical Microcrystalline Cellulose Sales Volume, by Application (2019-2030)
4.3.3 Global Pharmaceutical Microcrystalline Cellulose Sales Volume, by Application (%) (2019-2030)
4.4 Global Pharmaceutical Microcrystalline Cellulose Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Region
5.1.1 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Microcrystalline Cellulose Sales Value by Region (%), (2019-2030)
5.2 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Region
5.2.1 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Region (2019-2024)
5.2.3 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Region (2025-2030)
5.2.4 Global Pharmaceutical Microcrystalline Cellulose Sales Volume by Region (%), (2019-2030)
5.3 Global Pharmaceutical Microcrystalline Cellulose Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
5.4.2 North America Pharmaceutical Microcrystalline Cellulose Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
5.5.2 Europe Pharmaceutical Microcrystalline Cellulose Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
5.6.2 Asia Pacific Pharmaceutical Microcrystalline Cellulose Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
5.7.2 South America Pharmaceutical Microcrystalline Cellulose Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
5.8.2 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Microcrystalline Cellulose Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Microcrystalline Cellulose Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pharmaceutical Microcrystalline Cellulose Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.5.2 China Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Microcrystalline Cellulose Sales Value, 2019-2030
6.9.2 India Pharmaceutical Microcrystalline Cellulose Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Microcrystalline Cellulose Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 International Flavors & Fragrances
7.1.1 International Flavors & Fragrances Company Information
7.1.2 International Flavors & Fragrances Introduction and Business Overview
7.1.3 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.1.4 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Product Offerings
7.1.5 International Flavors & Fragrances Recent Development
7.2 JRS Pharma
7.2.1 JRS Pharma Company Information
7.2.2 JRS Pharma Introduction and Business Overview
7.2.3 JRS Pharma Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.2.4 JRS Pharma Pharmaceutical Microcrystalline Cellulose Product Offerings
7.2.5 JRS Pharma Recent Development
7.3 Shin-Etsu Chemical Co., Ltd.
7.3.1 Shin-Etsu Chemical Co., Ltd. Company Information
7.3.2 Shin-Etsu Chemical Co., Ltd. Introduction and Business Overview
7.3.3 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Offerings
7.3.5 Shin-Etsu Chemical Co., Ltd. Recent Development
7.4 Ashland
7.4.1 Ashland Company Information
7.4.2 Ashland Introduction and Business Overview
7.4.3 Ashland Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ashland Pharmaceutical Microcrystalline Cellulose Product Offerings
7.4.5 Ashland Recent Development
7.5 Asahi Kasei
7.5.1 Asahi Kasei Company Information
7.5.2 Asahi Kasei Introduction and Business Overview
7.5.3 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Product Offerings
7.5.5 Asahi Kasei Recent Development
7.6 Mingtai
7.6.1 Mingtai Company Information
7.6.2 Mingtai Introduction and Business Overview
7.6.3 Mingtai Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mingtai Pharmaceutical Microcrystalline Cellulose Product Offerings
7.6.5 Mingtai Recent Development
7.7 Huzhou Zhanwang
7.7.1 Huzhou Zhanwang Company Information
7.7.2 Huzhou Zhanwang Introduction and Business Overview
7.7.3 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Product Offerings
7.7.5 Huzhou Zhanwang Recent Development
7.8 Sunhere Pharmaceutical Excipients
7.8.1 Sunhere Pharmaceutical Excipients Company Information
7.8.2 Sunhere Pharmaceutical Excipients Introduction and Business Overview
7.8.3 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Product Offerings
7.8.5 Sunhere Pharmaceutical Excipients Recent Development
7.9 Shandong HEAD
7.9.1 Shandong HEAD Company Information
7.9.2 Shandong HEAD Introduction and Business Overview
7.9.3 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Product Offerings
7.9.5 Shandong HEAD Recent Development
7.10 Lotte Chemicals
7.10.1 Lotte Chemicals Company Information
7.10.2 Lotte Chemicals Introduction and Business Overview
7.10.3 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Product Offerings
7.10.5 Lotte Chemicals Recent Development
7.11 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
7.11.1 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Company Information
7.11.2 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Introduction and Business Overview
7.11.3 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Product Offerings
7.11.5 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Recent Development
7.12 Yingkou AODA Pharmaceuticals
7.12.1 Yingkou AODA Pharmaceuticals Company Information
7.12.2 Yingkou AODA Pharmaceuticals Introduction and Business Overview
7.12.3 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Product Offerings
7.12.5 Yingkou AODA Pharmaceuticals Recent Development
7.13 Accent Microcell
7.13.1 Accent Microcell Company Information
7.13.2 Accent Microcell Introduction and Business Overview
7.13.3 Accent Microcell Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Accent Microcell Pharmaceutical Microcrystalline Cellulose Product Offerings
7.13.5 Accent Microcell Recent Development
7.14 Qufu TIANLI MEDICAL Supplements
7.14.1 Qufu TIANLI MEDICAL Supplements Company Information
7.14.2 Qufu TIANLI MEDICAL Supplements Introduction and Business Overview
7.14.3 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Product Offerings
7.14.5 Qufu TIANLI MEDICAL Supplements Recent Development
7.15 C & J Chemical Industries Co., Ltd.
7.15.1 C & J Chemical Industries Co., Ltd. Company Information
7.15.2 C & J Chemical Industries Co., Ltd. Introduction and Business Overview
7.15.3 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2019-2024)
7.15.4 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Offerings
7.15.5 C & J Chemical Industries Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Microcrystalline Cellulose Industrial Chain
8.2 Pharmaceutical Microcrystalline Cellulose Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Microcrystalline Cellulose Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Microcrystalline Cellulose Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

International Flavors & Fragrances
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
Ashland
Asahi Kasei
Mingtai
Huzhou Zhanwang
Sunhere Pharmaceutical Excipients
Shandong HEAD
Lotte Chemicals
Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
Yingkou AODA Pharmaceuticals
Accent Microcell
Qufu TIANLI MEDICAL Supplements
C & J Chemical Industries Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.